We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App





AllTest Biotech Showcases Comprehensive Rapid and Immunoassay Diagnostics at MEDICA 2025

By LabMedica International staff writers
Posted on 19 Nov 2025

Hangzhou AllTest Biotech is showcasing its rapid diagnostic kits and immunoassay platforms at MEDICA 2025. More...

At Booth G11 in Hall 1, the company’s exhibit highlights a wide array of pioneering products across key categories.

AllTest’s comprehensive test lines feature state-of-the-art technologies, such lateral flow immunoassays with portable reader options, fluorescence immunoassay devices, dry biochemistry analyzers, and chemiluminescence immunoassay systems.

Newly launched items include a multiplex respiratory antigen rapid test for swift respiratory pathogen detection, a streamlined Drink Check Test, and a one‑step HIV 1.2 Rapid Test that delivers results in 15 minutes. The lineup also introduces tools for stomach health assessment and viral diarrhea diagnosis.

Established products on display include the hCG Pregnancy Rapid Test (compatible with visual and digital reading); the all‑in‑one Home Use Test Series covering UTI, ovulation, and pregnancy; the HBsAg Rapid Test; and an FDA‑approved Multi‑Drug 2–20 Drugs Rapid Test.

Attendees can review how the platforms align with laboratory and point‑of‑care workflows, from rapid antigen screening to automated immunoassay processing. The company’s experts will be available to show how the company's solutions boost diagnostic speed and transform patient care.

Related Links:
Hangzhou AllTest Biotech


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Platinum Member
Integrated Biochemical & Immunological System
Biolumi CX Solution X10+C10
New
Gold Member
Serum Indices Control
Acusera Serum Indices Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Blood proteins measured years before diagnosis may signal future prostate cancer risk, including aggressive disease.(Image Credit: iStock)

Blood Proteins Reveal Signals Linked to Prostate Cancer Risk Years Before Diagnosis

Prostate cancer is the most commonly diagnosed cancer in men worldwide. While many tumors grow slowly, aggressive forms can be life-threatening, underscoring the need for earlier risk identification.... Read more

Immunology

view channel
Image Credit: iStock

Antibody Profiling Predicts Inflammatory Bowel Disease Years Before Diagnosis

Inflammatory bowel disease (IBD), which includes Crohn’s disease and ulcerative colitis, involves abnormal immune responses that cause persistent inflammation and damage in the digestive system.... Read more

Pathology

view channel
Image Credit: iStock

AI Tissue Analysis May Help Identify Missed Precancerous Colon Polyps

Colorectal cancer is diagnosed in an estimated 1.9 million people worldwide each year, often without symptoms in its early stages. Timely detection of precancerous lesions is therefore important, yet some... Read more

Technology

view channel
Image: Signals LabGistics uses AI to turn natural-language instructions and SOPs into coordinated scientific workflows, helping connect teams, systems, and processes. (Photo courtesy of Revvity)

New AI-Powered System Aims to Streamline Laboratory and Manufacturing Workflows

Scientific laboratories supporting drug development, biotechnology, and materials research increasingly rely on coordinated digital workflows to move data, samples, and activities across teams.... Read more

Industry

view channel
Image: Beginning in 2027, Quest will provide access to the Onclarity Self-Collection Kit through clinician, health plan, and consumer-initiated testing channels, along with its patient service center network.

Collaboration to Expand Cervical Cancer Screening Access With At-Home HPV Collection

Cervical cancer is largely preventable with regular screening and early detection of human papillomavirus (HPV), the leading cause of the disease. Screening gaps persist, in part because traditional sample... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.